Search Results Page

Sterling Biotech hits new high

about 13 years ago

Sterling Biotech has been on the rise since the past two days, hitting upper circuits. Today, it has hit a new 52-week high at Rs.9.67 and currently remains up around 6%. The stock is up on the back of the news which the company announced on 20th Nov after market hours. The company stated th ...

Panacea Biotech surges almost 15%

about 10 years ago

Panacea Biotech rose almost 15% to Rs.145, just Rs.10 short of its 52-week high of Rs.155. The market is thrilled as the company has received the US FDA approval for Rizatripan Bonzoate tablet, which is used to treat symptoms due to migraine. The current annual sale of this drug in ...

Panacea Biotech

about 10 years ago

Panacea Biotech rallied over 1.3% in the early morning trades to Rs.163.20 and continues to remain in the green. Volumes have shown a spike up of over 2.5 times. Its 52-week high is at Rs.178.30

Panacea Biotech surges up over 10%

about 10 years ago

Panacea Biotech is up in the green today morning, with the stock price rising over 10% at Rs.127; it has come off this intra day high since then and is now at Rs.120 levels, up over 4.5%. Its 52-week high is at Rs.155. The market is happy after it announced that it has launched a fully-liqui ...

Panacea Biotech scores a century

about 13 years ago

Share price of vaccine maker Panacea Biotech has breached the three digit mark and now ruling up 5% at Rs. 100.40. Company announced quarter results for three months ended 31st December 2013, yesterday after market close. While sales were flat QoQ to Rs. 112 crore, its PAT increased to Rs. 83 cro ...

Concord Biotech among gainers

about 2 years ago

The stock is among the top five gainers on the BSE today morning; the stock opened almost status quo but soon jumped up to an intraday high at Rs.1993, up 5%.

Panacea Biotech up 20%

about 6 years ago

From its close of Rs.184.05 yesterday, it today opened at Rs.212.90, going on to briefly skim the 20% UC of the day at Rs.220.85. Its 52-week high stands at Rs.265.

Rossari Biotech surges

about 6 years ago

The stock today continued with its surge, rising to hit an intraday high at Rs.794.25, with a market cap close to Rs.4000 crore.

Sterling Biotech hits 5% LC

about 8 years ago

The stock as such is a penny stock, hardly worthy of anything on the bourses. Yet today, it fell further to hit a new low at 73 paise, breaching the 5% LC.

Windlas Biotech

about 5 years ago

Verdict :Just Not Recommended
Subscription Start Date :4 Aug 2021 End Date :6 Aug 2021
Issue Size : 402 cr, Issue Type : Fresh cum OFS
Price Band : Rs.448 to Rs. 460
--------------------------------------------------
Overall Subscription : 22.47x
QIB : 24.4x,HNI :15.73x,Retail :24.27x
Listing Date : 16 Aug 2021, , Listing Price : 439

Rossari Biotech

about 6 years ago

Verdict :Growth justifies aggressive pricing
Subscription Start Date :13 Jul 2020 End Date :15 Jul 2020
Issue Size : 496 crore, Issue Type : Fresh cum OFS
Price Band : Rs.423 to Rs. 425
--------------------------------------------------
Overall Subscription : 79.37x
QIB : 85.26x,HNI :239.83x,Retail :7.23x
Listing Date : 23 Jul 2020, , Listing Price : 670

Saamya Biotech

about 19 years ago

Price Band : Rs. - to Rs. -
--------------------------------------------------

Concord Biotech

about 3 years ago

Ready to Take Off
Subscription Start Date :4 Aug 2023 End Date :8 Aug 2023
Issue Size : 1,551 cr, Issue Type : OFS
Price Band : Rs.705 to Rs. 741
--------------------------------------------------
Overall Subscription : 24.86x
QIB : 67.67x,HNI :17x,Retail :3.78x,Other :24.47x
Listing Date : 18 Aug 2023, , Listing Price : 900

Panacea Biotech at 5% LC

about 6 years ago

The stock, which had closed yesterday at Rs.194.15 within a few minutes of opening hit the 5% LC of the day at Rs.184.45

Panacea Biotech at 5% UC

about 5 years ago

The stock which had closed yesterday at Rs.263.80, opened itself today at its 5% UC of the day at Rs.276.95. Its 52-week high is at Rs.453.70.

Panacea Biotech hits new high

about 4 months ago

The stock surged to a new 52-week high of Rs. 637.70 and was trading around Rs. 632, up 14.23%, after the company disclosed its participation in the DENSTAR programme linked to its tetravalent dengue vaccine candidate DengiAll.

Panacea Bio in the green

about 13 years ago

Panacea Biotech has been on the green run for a couple of days now. The stock is up today too, up almost 12% at Rs.137.10, with an intra day high and low at Rs.142 and Rs.125.40. Volumes are up almost 3 times at 67,000 shares. The stock is up as bargain hunters look for opportunities to take ...

Hester Bioscience up 14%

about 5 years ago

the stock opened itself with a huge gap, up over 11% at Rs.3020 and went on further to Rs.3099, a surge of 14% but profit booking at this level, pushed the stock down

Bayer Crop at new high

about 10 years ago

Bayer Crop Science hit a new 52-week high today at Rs.4380 and Monsanto went on to an intra day high at Rs.2728.90, close to its 52-week high of Rs.2744.85. In this otherwise lackluster market, these two agri stocks are shining bright because of the obvious deal - German chemical and pharma ...

Emami looking pretty

about 12 years ago

Emami is looking pretty “fair and handsome” in this otherwise fragile market. Figuring amongst the top gainers, the stock opened higher at Rs.1085, going up to an intra day high of Rs.1117 and it is currently at Rs.1101, up Rs.34 or by almost 3.5%. The market is reacting today to ...

Monsanto hits a new low

about 11 years ago

Monsanto India is beaten down to pulp today. The stock hit a new 52-week low at Rs.1900.20 and remains now at around Rs.1930 levels. The mood on the counter remains very somber. The company is down as Competition Commission of India (CCI) has ordered an investigation into its JV, suspecting ...

Concord flies high

about 3 years ago

Listing on the BSE at Rs.900.05, it rose to Rs.982.65 and is currently trading around the same levels. This is a huge premium over the IPO price of Rs.741/share.

Zydus Life down 6%

about 2 years ago

The stock is among the top five losers on the BSE since the opening bell today; opening 2.5% lower at Rs.1148.95, the stock price fell down further to an intraday low at Rs.1109, down 6%.

Two dull listings

about 1 year ago

Two new listings today – one was dull and the other was even more dull. Fabtech Tech got listed at Rs.192 v/s IPO price of Rs.191 and is now trading at Rs.181.55.

'EXPECTATIONS OF D-DAY SPEECH?' - WHERE ARE WE HEADED?

about 12 years ago

But when we come across lesser and lesser reasons to celebrate, we tend to get more 'micro'. looking for triggers even in the most routine things. Like the current build up on expectations from Modi's Independence Day speech.

Sun Pharma jumps up

about 12 years ago

Sun Pharma is showing some traction in this overall lackluster market. The stock, opened some Rs.10 higher at Rs.956, going up to Rs.960 levels and with profit booking coming at these levels, it has now slipped back to Rs.956, up over 1%. Volumes remain muted. Its 52-weke high is at Rs.1200.70. ...

GOING GLOBAL - ARE INDIAN COMPANIES GETTING LISTED ABROAD?

about 11 years ago

If you have ever visited the New York Stock Exchange (NYSE), it is quite a feeling to see some Indian company's quotes showing up on the screen. And the small, handful of companies listed on the NYSE are some of the best that we have in India - Dr. Reddy's Labs, HDFC Bank, ICICI Bank, Tata Communication, Wipro, Tata Motors, WSN Holdings and Sesa Sterlite.

Fabtech Technologies

about 1 year ago

Nothing Fabulous about it
Subscription Start Date :29 Sep 2025 End Date :1 Oct 2025
Issue Size : Rs. 230 cr, Issue Type : Fresh Issue
Price Band : Rs.181 to Rs. 191
--------------------------------------------------
Overall Subscription : 2.03x
QIB : 2.02x,HNI :1.97x,Retail :2.08x,Other :2.01x
Listing Date : 7 Oct 2025, , Listing Price : 191

Chemcel Bio-Tech

about 18 years ago

Price Band : Rs. - to Rs. -
--------------------------------------------------

VACCINATION- LIKE INDIAN TRAINS, ARRIVAL TIME UNKNOWN!

about 6 years ago

For all around the world, it was the ‘Oxford’ vaccine which holds the maximum hope. Russia and China already have a vaccine and they are probably closer to getting it to people than Astrazeneca; yet their news produces no excitement – who in this world trusts anything when it comes to Russia and China?

RS.3 PEN TIED IN BANKS WHILE SCAMSTERS EMPTY THE COFFERS!

about 9 years ago

The horses have run out of the stable and the door is now being closed. That’s how one feels on reading that 36 scamsters have already fled the country and we are left sifting through the muck, working relentlessly on extradition while the tax payers money gets wasted, time and again. While RBI and finance ministry continue with their blame game, we can only watch helplessly as banks get heisted.

MONSANTO INDIA - SOWING SEEDS OF DISCONTENT AND DOUBT

about 11 years ago

Monsanto is having a tough time. Or as many would say, it is reaping today what it had sowed. The very same seeds which it had sold to the farmers have come to haunt the company. Recently the stock was beaten down to pulp, hitting a new 52-week low after the Competition Commission of India (CCI) ordered an investigation into its JV, suspecting the company had abused its dominant position as a supplier of genetically modified (GM) cotton seeds. The CCI had also asked the

Concord Bio attracts attention

about 4 months ago

The stock is trading marginally higher today morning The stock was up 0.53% at Rs. 1,333.85 on the NSE, tracking a regulatory-led uptick even as investors remain mindful of the company’s softer Q4FY26 print.